Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

OneMedNet (ONMD) Research & Development (2022 - 2025)

Historic Research & Development for OneMedNet (ONMD) over the last 4 years, with Q3 2025 value amounting to $323000.0.

  • OneMedNet's Research & Development rose 838.93% to $323000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 1427.69%. This contributed to the annual value of $1.5 million for FY2024, which is 2895.88% down from last year.
  • OneMedNet's Research & Development amounted to $323000.0 in Q3 2025, which was up 838.93% from $382000.0 recorded in Q2 2025.
  • OneMedNet's 5-year Research & Development high stood at $880638.0 for Q4 2022, and its period low was $298000.0 during Q3 2024.
  • For the 4-year period, OneMedNet's Research & Development averaged around $455386.5, with its median value being $394000.0 (2023).
  • In the last 5 years, OneMedNet's Research & Development plummeted by 4333.65% in 2023 and then skyrocketed by 838.93% in 2025.
  • OneMedNet's Research & Development (Quarter) stood at $880638.0 in 2022, then crashed by 43.34% to $499000.0 in 2023, then plummeted by 31.86% to $340000.0 in 2024, then fell by 5.0% to $323000.0 in 2025.
  • Its Research & Development was $323000.0 in Q3 2025, compared to $382000.0 in Q2 2025 and $348000.0 in Q1 2025.